查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1587598

2030 年製药自动化市场预测：按产品、工作流程类型、自动化规模、技术、应用、最终用户和地区进行的全球分析

Pharmaceutical Automation Market Forecasts to 2030 - Global Analysis By Product, Workflow Type, Scale of Automation, Technology, Application, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3个工作天内

价格

根据Stratistics MRC预测，2024年全球製药自动化市场规模将达57.9亿美元，预计2030年将达到94.6亿美元，预测期内复合年增长率为9.8%。

製药自动化是指使用科技和机械来简化和增强製药业的流程。这包括自动化任务，如配方、包装、标籤和品管，以提高效率、减少人为错误并确保符合监管标准。透过整合这些技术，製药公司可以提高生产力，降低业务成本，并最终为患者提供更安全、更有效的药物。

根据全国社区药剂师协会 2020 年 4 月进行的一项调查，大约 90% 的社区药局根据 CARES 法案申请了联邦小型企业援助。

慢性病增加

糖尿病、心血管疾病和癌症等慢性疾病的增加正在推动对高效、可扩展的製药生产的需求。随着製药公司努力满足不断增长的药品需求，自动化技术可以增强製造流程，从而加快生产速度并改善品管。自动化系统可以简化工作流程，最大限度地减少人为错误，并确保一致的产品质量，这对于慢性病管理至关重要。

复杂的整合

製药自动化的整合复杂性源自于需要将先进技术与现有系统和流程同步，这通常涉及遗留设备和不同的软体平台。这种整合在技术上具有挑战性，需要大量时间和资源来确保相容性和效率。这种复杂性可能会导致计划进度更长、成本更高以及生产中断。结果，市场扩张受到阻碍。

越来越多地转向客製化治疗

自动化技术使製药公司能够快速调整其生产线来生产个人化药物，同时确保精确的剂量和剂量以满足患者的需求。这种製造弹性缩短了新治疗方法的上市时间，并增强了满足特定监管要求的能力。此外，自动化系统改善了资料管理和可追溯性，这对于追踪个人化治疗结果至关重要，从而推动了製药业对先进自动化解决方案的需求。

初始投资高

製药自动化的初始投资较高是由于先进技术、设备和系统整合的相关成本。实施自动化解决方案需要大量的机械、软体和人力资源资本，这可能令人望而却步，特别是对于中小型企业而言。这种经济负担可能会阻碍对自动化的投资并限制市场内的成长机会。

COVID-19 的影响

随着公司寻求简化药品生产并确保安全，COVID-19 大流行显着加速了製药自动化市场的发展。对疫苗和治疗方法的迫切需求导致对机器人和人工智慧等自动化技术的投资增加，以简化製造流程。此外，疫情凸显了数位转型和即时资料管理对于维持供应链弹性的重要性。因此，在对创新解决方案的持续需求和业务效率提高的推动下，製药自动化市场预计将成长。

云端运算产业预计将在预测期内成为最大的产业

预计云端运算领域将在整个预测期内获得最大的市场占有率。云端运算技术为资料储存、管理和分析提供可扩展且灵活的解决方案，正在彻底改变製药自动化。实现对关键资讯的即时访问，并促进研究、製造和监管团队之间的无缝协作。透过利用云端技术，製药公司可以提高业务效率、降低成本、缩短药物开发时间，并最终改善患者治疗效果。

预计生产和製造领域在预测期内复合年增长率最高。

由于药物开发的效率、准确性和合规性提高，预计生产和製造业在预测期内将出现最高的复合年增长率。自动化系统简化了配方、包装、标籤和品管等流程，减少了人为错误并提高了吞吐量。自动化还实现了灵活的製造，使公司能够快速回应不断变化的市场需求和个人化医疗。总的来说，这些应用程式有助于提高业务效率并缩短时间。

比最大的地区

由于慢性病的增加，预计亚太地区在预测期内将创下最大的市场占有率。中国和印度等国家正大力投资自动化技术。该地区製药业的成长，加上机器人、人工智慧和机器学习的进步，正在推动这一转变。此外，对生物製药行业研发和扩张的持续关注进一步推动了整个全部区域自动化解决方案的采用。

复合年增长率最高的地区：

预计北美在预测期内的复合年增长率最高。美国和加拿大处于领先地位，投资机器人、人工智慧和先进製造系统，以提高业务效率并确保监管合规。该地区专注于研发，对个人化医疗和生技药品的需求不断增长，刺激了自动化技术的采用。此外，COVID-19 大流行加速了自动化的发展，凸显了对弹性和敏捷製造流程的需求。

免费客製化服务：

订阅此报告的客户可以存取以下免费自订选项之一：

  • 公司简介
    • 其他市场参与者的综合分析（最多 3 家公司）
    • 主要企业SWOT分析（最多3家企业）
  • 区域分割
    • 根据客户兴趣对主要国家的市场估计、预测和复合年增长率（註：基于可行性检查）
  • 竞争标基准化分析
    • 根据产品系列、地理分布和策略联盟对主要企业基准化分析

目录

第一章执行摘要

第二章 前言

  • 概述
  • 相关利益者
  • 调查范围
  • 调查方法
    • 资料探勘
    • 资料分析
    • 资料检验
    • 研究途径
  • 研究资讯来源
    • 主要研究资讯来源
    • 二次研究资讯来源
    • 先决条件

第三章市场趋势分析

  • 促进因素
  • 抑制因素
  • 机会
  • 威胁
  • 产品分析
  • 技术分析
  • 应用分析
  • 最终用户分析
  • 新兴市场
  • COVID-19 的影响

第4章波特五力分析

  • 供应商的议价能力
  • 买方议价能力
  • 替代品的威胁
  • 新进入者的威胁
  • 竞争公司之间的敌对关係

第五章全球製药自动化市场：依产品

  • 自动化设备
    • 机器人技术
    • 自动导引运输车（AGV）
    • 自动化立体仓库系统（AS/RS）
  • 软体解决方案
    • 製造执行系统（MES）
    • 实验室资讯管理系统（LIMS）
    • 供应链管理软体
  • 服务
    • 咨询
    • 综合服务
    • 维护与支援

第六章全球製药自动化市场：依工作流程类型

  • 分析前
  • 分析性的
  • 分析后

第七章全球製药自动化市场：依自动化规模分类

  • 手动集成
  • 部分自动化
  • 全自动

第八章全球製药自动化市场：依技术分类

  • 人工智慧（AI）
  • 物联网 (IoT)
  • 机器学习
  • 云端运算
  • 资料分析
  • 其他技术

第九章全球製药自动化市场：依应用分类

  • 药物发现
  • 临床试验
  • 生产製造
  • 品管与保证
  • 监理合规性
  • 其他用途

第10章全球製药自动化市场：依最终用户分类

  • 药品製造商
  • 受託研究机构（CRO）
  • 契约製造组织 (CMO)
  • 生技公司
  • 研究所
  • 其他最终用户

第十一章全球製药自动化市场：按地区

  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 义大利
    • 法国
    • 西班牙
    • 其他欧洲国家
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 纽西兰
    • 韩国
    • 其他亚太地区
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地区
  • 中东/非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 卡达
    • 南非
    • 其他中东和非洲

第十二章 主要进展

  • 合约、伙伴关係、协作和合资企业
  • 收购和合併
  • 新产品发布
  • 业务拓展
  • 其他关键策略

第十三章 公司概况

  • Siemens AG
  • Rockwell Automation Inc.
  • ABB Limited
  • Honeywell International Inc.
  • Emerson Electric Corporation
  • Schneider Electric SE
  • Mitsubishi Electric Corporation
  • Bosch Rexroth AG
  • Yokogawa Electric Corporation
  • Omron Corporation
  • KUKA AG
  • Fanuc Corporation
  • Adept Technology Inc.
  • Parker Hannifin Corporation
  • Datalogic SpA
  • Panasonic Corporation
  • GE Healthcare
  • Ametek Inc.
  • Festo AG & Co. KG
  • B&R Industrial Automation
  • ArisGlobal
  • Beckhoff Automation GmbH
Product Code: SMRC27583

According to Stratistics MRC, the Global Pharmaceutical Automation Market is accounted for $5.79 billion in 2024 and is expected to reach $9.46 billion by 2030 growing at a CAGR of 9.8% during the forecast period. Pharmaceutical automation refers to the use of technology and machinery to streamline and enhance processes within the pharmaceutical industry. This includes automating tasks such as drug formulation, packaging, labeling, and quality control to improve efficiency, reduce human error, and ensure compliance with regulatory standards. By integrating these technologies, pharmaceutical companies can enhance productivity, reduce operational costs, and ultimately deliver safer and more effective medications to patients.

According to a study conducted by the National Community Pharmacists Association in April 2020, around 90% of community pharmacies were applying for small business federal aid under the CARES Act.

Market Dynamics:

Driver:

Rising prevalence of chronic diseases

The rising prevalence of chronic diseases, such as diabetes, cardiovascular diseases, and cancer increases the demand for efficient and scalable drug production. As pharmaceutical companies strive to meet the growing need for medications, automation technologies enhance manufacturing processes, allowing for quicker production and improved quality control. Automated systems can streamline workflows, minimize human error, and ensure consistent product quality, which is crucial for chronic disease management.

Restraint:

Complexity of integration

The complexity of integration in pharmaceutical automation arises from the need to synchronize advanced technologies with existing systems and processes, which often involves legacy equipment and diverse software platforms. This integration can be technically challenging, requiring significant time and resources to ensure compatibility and efficiency. Such complexities can lead to prolonged project timelines, increased costs, and potential disruptions in production. As a result, it impedes the market expansion.

Opportunity:

Growing shift towards customized treatments

Automation technologies enable pharmaceutical companies to quickly adapt production lines to create individualized medications, ensuring precise dosages and formulations tailored to patient needs. This agility in manufacturing reduces time-to-market for new therapies and enhances the ability to meet specific regulatory requirements. Additionally, automated systems improve data management and traceability, essential for tracking personalized treatment outcomes, thereby driving the demand for advanced automation solutions within the pharmaceutical industry.

Threat:

High initial investment

The high initial investment in pharmaceutical automation stems from the costs associated with advanced technologies, equipment, and system integration. Implementing automation solutions requires significant capital for machinery, software, and training personnel, which can be prohibitive, especially for small to mid-sized companies. This financial burden may deter investment in automation, limiting growth opportunities within the market.

Covid-19 Impact

The covid-19 pandemic significantly accelerated the pharmaceutical automation market, as companies sought to enhance efficiency and ensure safety in drug production. The urgent need for vaccines and treatments led to increased investments in automation technologies, such as robotics and AI, to streamline manufacturing processes. Additionally, the pandemic highlighted the importance of digital transformation and real-time data management in maintaining supply chain resilience. As a result, the pharmaceutical automation market is expected to grow, driven by ongoing demand for innovative solutions and improved operational efficiencies.

The cloud computing segment is expected to be the largest during the forecast period

The cloud computing segment is predicted to secure the largest market share throughout the forecast period. Cloud computing technology is revolutionizing pharmaceutical automation by providing scalable and flexible solutions for data storage, management, and analysis. It enables real-time access to critical information, facilitating seamless collaboration among research, manufacturing, and regulatory teams. By leveraging cloud technology, pharmaceutical companies can improve operational efficiency, reduce costs, and accelerate drug development timelines, ultimately leading to better patient outcomes.

The production & manufacturing segment is expected to have the highest CAGR during the forecast period

The production & manufacturing segment is anticipated to witness the highest CAGR during the forecast period fuelled by its enhanced efficiency, accuracy, and compliance in drug development. Automated systems streamline processes such as formulation, packaging, labeling, and quality control, reducing human error and increasing throughput. Automation also facilitates flexible manufacturing, allowing companies to quickly adapt to changing market demands and personalized medicine. Overall, these applications contribute to improved operational efficiency and faster time-to-market for pharmaceuticals.

Region with largest share:

Asia Pacific is expected to register the largest market share during the forecast period driven by rising prevalence of chronic diseases. Countries like China and India are investing heavily in automation technologies. The region's growing pharmaceutical industry, coupled with advancements in robotics, artificial intelligence, and machine learning, is facilitating this transformation. Additionally, the ongoing focus on research and development, along with an expanding biopharmaceutical sector, is further propelling the adoption of automation solutions across the region.

Region with highest CAGR:

North America is projected to witness the highest CAGR over the forecast period. The United States and Canada are leading this trend, with investments in robotics, artificial intelligence, and advanced manufacturing systems to enhance operational efficiency and ensure regulatory compliance. The region's strong emphasis on research and development, alongside the rising demand for personalized medicine and biologics, is fueling the adoption of automation technologies. Furthermore, the covid-19 pandemic has accelerated the push towards automation, emphasizing the need for resilient and agile manufacturing processes.

Key players in the market

Some of the key players profiled in the Pharmaceutical Automation Market include Siemens AG, Rockwell Automation Inc., ABB Limited, Honeywell International Inc., Emerson Electric Corporation, Schneider Electric SE, Mitsubishi Electric Corporation, Bosch Rexroth AG, Yokogawa Electric Corporation, Omron Corporation, KUKA AG, Fanuc Corporation, Adept Technology Inc., Parker Hannifin Corporation, Datalogic S.p.A., Panasonic Corporation, GE Healthcare, Ametek Inc., Festo AG & Co. KG, B&R Industrial Automation, ArisGlobal and Beckhoff Automation GmbH.

Key Developments:

In May 2024, ArisGlobal unveiled its enhanced LifeSphere Automation Engine, a significant advancement aimed at revolutionizing the pharmaceutical industry's safety and regulatory processes. This launch emphasizes the integration of artificial intelligence (AI) into the company's existing framework, enabling pharmaceutical organizations to streamline their operations and enhance data management capabilities.

In April 2024, GE Healthcare unveiled its suite of AI-Enhanced Personalized Oncology Solutions. This innovative technology is designed to significantly improve the precision and effectiveness of cancer treatments through advanced automation and machine learning techniques. This personalization is expected to enhance outcomes by aligning therapies more closely with patients' specific cancer profiles.

Products Covered:

  • Automated Equipment
  • Software Solutions
  • Services

Workflow Types Covered:

  • Pre-analytical
  • Analytical
  • Post-analytical

Scale of Automations Covered:

  • Manual Integration
  • Partial Automation
  • Full Automation

Technologies Covered:

  • Artificial Intelligence (AI)
  • Internet of Things (IoT)
  • Machine Learning
  • Cloud Computing
  • Data Analytics
  • Other Technologies

Applications Covered:

  • Drug Discovery
  • Clinical Trials
  • Production & Manufacturing
  • Quality Control & Assurance
  • Regulatory Compliance
  • Other Applications

End Users Covered:

  • Pharmaceutical Manufacturers
  • Contract Research Organizations (CROs)
  • Contract Manufacturing Organizations (CMOs)
  • Biotechnology Companies
  • Research Institutions
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2022, 2023, 2024, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 Technology Analysis
  • 3.8 Application Analysis
  • 3.9 End User Analysis
  • 3.10 Emerging Markets
  • 3.11 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Pharmaceutical Automation Market, By Product

  • 5.1 Introduction
  • 5.2 Automated Equipment
    • 5.2.1 Robotics
    • 5.2.2 Automated Guided Vehicles (AGVs)
    • 5.2.3 Automated Storage & Retrieval Systems (AS/RS)
  • 5.3 Software Solutions
    • 5.3.1 Manufacturing Execution Systems (MES)
    • 5.3.2 Laboratory Information Management Systems (LIMS)
    • 5.3.3 Supply Chain Management Software
  • 5.4 Services
    • 5.4.1 Consulting
    • 5.4.2 Integration Services
    • 5.4.3 Maintenance & Support

6 Global Pharmaceutical Automation Market, By Workflow Type

  • 6.1 Introduction
  • 6.2 Pre-analytical
  • 6.3 Analytical
  • 6.4 Post-analytical

7 Global Pharmaceutical Automation Market, By Scale of Automation

  • 7.1 Introduction
  • 7.2 Manual Integration
  • 7.3 Partial Automation
  • 7.4 Full Automation

8 Global Pharmaceutical Automation Market, By Technology

  • 8.1 Introduction
  • 8.2 Artificial Intelligence (AI)
  • 8.3 Internet of Things (IoT)
  • 8.4 Machine Learning
  • 8.5 Cloud Computing
  • 8.6 Data Analytics
  • 8.7 Other Technologies

9 Global Pharmaceutical Automation Market, By Application

  • 9.1 Introduction
  • 9.2 Drug Discovery
  • 9.3 Clinical Trials
  • 9.4 Production & Manufacturing
  • 9.5 Quality Control & Assurance
  • 9.6 Regulatory Compliance
  • 9.7 Other Applications

10 Global Pharmaceutical Automation Market, By End User

  • 10.1 Introduction
  • 10.2 Pharmaceutical Manufacturers
  • 10.3 Contract Research Organizations (CROs)
  • 10.4 Contract Manufacturing Organizations (CMOs)
  • 10.5 Biotechnology Companies
  • 10.6 Research Institutions
  • 10.7 Other End Users

11 Global Pharmaceutical Automation Market, By Geography

  • 11.1 Introduction
  • 11.2 North America
    • 11.2.1 US
    • 11.2.2 Canada
    • 11.2.3 Mexico
  • 11.3 Europe
    • 11.3.1 Germany
    • 11.3.2 UK
    • 11.3.3 Italy
    • 11.3.4 France
    • 11.3.5 Spain
    • 11.3.6 Rest of Europe
  • 11.4 Asia Pacific
    • 11.4.1 Japan
    • 11.4.2 China
    • 11.4.3 India
    • 11.4.4 Australia
    • 11.4.5 New Zealand
    • 11.4.6 South Korea
    • 11.4.7 Rest of Asia Pacific
  • 11.5 South America
    • 11.5.1 Argentina
    • 11.5.2 Brazil
    • 11.5.3 Chile
    • 11.5.4 Rest of South America
  • 11.6 Middle East & Africa
    • 11.6.1 Saudi Arabia
    • 11.6.2 UAE
    • 11.6.3 Qatar
    • 11.6.4 South Africa
    • 11.6.5 Rest of Middle East & Africa

12 Key Developments

  • 12.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 12.2 Acquisitions & Mergers
  • 12.3 New Product Launch
  • 12.4 Expansions
  • 12.5 Other Key Strategies

13 Company Profiling

  • 13.1 Siemens AG
  • 13.2 Rockwell Automation Inc.
  • 13.3 ABB Limited
  • 13.4 Honeywell International Inc.
  • 13.5 Emerson Electric Corporation
  • 13.6 Schneider Electric SE
  • 13.7 Mitsubishi Electric Corporation
  • 13.8 Bosch Rexroth AG
  • 13.9 Yokogawa Electric Corporation
  • 13.10 Omron Corporation
  • 13.11 KUKA AG
  • 13.12 Fanuc Corporation
  • 13.13 Adept Technology Inc.
  • 13.14 Parker Hannifin Corporation
  • 13.15 Datalogic S.p.A.
  • 13.16 Panasonic Corporation
  • 13.17 GE Healthcare
  • 13.18 Ametek Inc.
  • 13.19 Festo AG & Co. KG
  • 13.20 B&R Industrial Automation
  • 13.21 ArisGlobal
  • 13.22 Beckhoff Automation GmbH

List of Tables

  • Table 1 Global Pharmaceutical Automation Market Outlook, By Region (2022-2030) ($MN)
  • Table 2 Global Pharmaceutical Automation Market Outlook, By Product (2022-2030) ($MN)
  • Table 3 Global Pharmaceutical Automation Market Outlook, By Automated Equipment (2022-2030) ($MN)
  • Table 4 Global Pharmaceutical Automation Market Outlook, By Robotics (2022-2030) ($MN)
  • Table 5 Global Pharmaceutical Automation Market Outlook, By Automated Guided Vehicles (AGVs) (2022-2030) ($MN)
  • Table 6 Global Pharmaceutical Automation Market Outlook, By Automated Storage & Retrieval Systems (AS/RS) (2022-2030) ($MN)
  • Table 7 Global Pharmaceutical Automation Market Outlook, By Software Solutions (2022-2030) ($MN)
  • Table 8 Global Pharmaceutical Automation Market Outlook, By Manufacturing Execution Systems (MES) (2022-2030) ($MN)
  • Table 9 Global Pharmaceutical Automation Market Outlook, By Laboratory Information Management Systems (LIMS) (2022-2030) ($MN)
  • Table 10 Global Pharmaceutical Automation Market Outlook, By Supply Chain Management Software (2022-2030) ($MN)
  • Table 11 Global Pharmaceutical Automation Market Outlook, By Services (2022-2030) ($MN)
  • Table 12 Global Pharmaceutical Automation Market Outlook, By Consulting (2022-2030) ($MN)
  • Table 13 Global Pharmaceutical Automation Market Outlook, By Integration Services (2022-2030) ($MN)
  • Table 14 Global Pharmaceutical Automation Market Outlook, By Maintenance & Support (2022-2030) ($MN)
  • Table 15 Global Pharmaceutical Automation Market Outlook, By Workflow Type (2022-2030) ($MN)
  • Table 16 Global Pharmaceutical Automation Market Outlook, By Pre-analytical (2022-2030) ($MN)
  • Table 17 Global Pharmaceutical Automation Market Outlook, By Analytical (2022-2030) ($MN)
  • Table 18 Global Pharmaceutical Automation Market Outlook, By Post-analytical (2022-2030) ($MN)
  • Table 19 Global Pharmaceutical Automation Market Outlook, By Scale of Automation (2022-2030) ($MN)
  • Table 20 Global Pharmaceutical Automation Market Outlook, By Manual Integration (2022-2030) ($MN)
  • Table 21 Global Pharmaceutical Automation Market Outlook, By Partial Automation (2022-2030) ($MN)
  • Table 22 Global Pharmaceutical Automation Market Outlook, By Full Automation (2022-2030) ($MN)
  • Table 23 Global Pharmaceutical Automation Market Outlook, By Technology (2022-2030) ($MN)
  • Table 24 Global Pharmaceutical Automation Market Outlook, By Artificial Intelligence (AI) (2022-2030) ($MN)
  • Table 25 Global Pharmaceutical Automation Market Outlook, By Internet of Things (IoT) (2022-2030) ($MN)
  • Table 26 Global Pharmaceutical Automation Market Outlook, By Machine Learning (2022-2030) ($MN)
  • Table 27 Global Pharmaceutical Automation Market Outlook, By Cloud Computing (2022-2030) ($MN)
  • Table 28 Global Pharmaceutical Automation Market Outlook, By Data Analytics (2022-2030) ($MN)
  • Table 29 Global Pharmaceutical Automation Market Outlook, By Other Technologies (2022-2030) ($MN)
  • Table 30 Global Pharmaceutical Automation Market Outlook, By Application (2022-2030) ($MN)
  • Table 31 Global Pharmaceutical Automation Market Outlook, By Drug Discovery (2022-2030) ($MN)
  • Table 32 Global Pharmaceutical Automation Market Outlook, By Clinical Trials (2022-2030) ($MN)
  • Table 33 Global Pharmaceutical Automation Market Outlook, By Production & Manufacturing (2022-2030) ($MN)
  • Table 34 Global Pharmaceutical Automation Market Outlook, By Quality Control & Assurance (2022-2030) ($MN)
  • Table 35 Global Pharmaceutical Automation Market Outlook, By Regulatory Compliance (2022-2030) ($MN)
  • Table 36 Global Pharmaceutical Automation Market Outlook, By Other Applications (2022-2030) ($MN)
  • Table 37 Global Pharmaceutical Automation Market Outlook, By End User (2022-2030) ($MN)
  • Table 38 Global Pharmaceutical Automation Market Outlook, By Pharmaceutical Manufacturers (2022-2030) ($MN)
  • Table 39 Global Pharmaceutical Automation Market Outlook, By Contract Research Organizations (CROs) (2022-2030) ($MN)
  • Table 40 Global Pharmaceutical Automation Market Outlook, By Contract Manufacturing Organizations (CMOs) (2022-2030) ($MN)
  • Table 41 Global Pharmaceutical Automation Market Outlook, By Biotechnology Companies (2022-2030) ($MN)
  • Table 42 Global Pharmaceutical Automation Market Outlook, By Research Institutions (2022-2030) ($MN)
  • Table 43 Global Pharmaceutical Automation Market Outlook, By Other End Users (2022-2030) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.